SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📊Dashboards🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
clinical 1,914 words KG: UB-311 Alzheimer's Vaccination Trial
Contents

UB-311 Alzheimer's Vaccination Trial

No AI portrait yet

Knowledge Graph

Related Hypotheses (16)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76APOE Isoform Conversion Therapy
Score: 0.72Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72Phase-Separated Organelle Targeting
Score: 0.73Competitive APOE4 Domain Stabilization Peptides
Score: 0.78Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.78Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76APOE Isoform Expression Across Glial Subtypes
Score: 0.74APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72Orexin-Microglia Modulation Therapy
Score: 0.71Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67

Related Analyses (8)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completedTREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completedGut-Brain Axis Therapeutics for AD
neurodegeneration · completedCell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archivedCell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived

Related Experiments (2)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40

See Also (15)

Donanemab TRAILBLAZER-ALZ 2 Trial
clinical · Pages share 4 hypothesesLX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 4 hypothesesal002-trem2-agonist-alzheimers
clinical_trial · Pages share 4 hypothesesDBS Nucleus Basalis Trial (NCT07218081): Deep Brain Sti
clinical · Pages share 4 hypothesesMK-1167 Phase 2 AD Trial (MK-1167-008)
clinical · Pages share 4 hypotheses

Knowledge Graph (1 edges)

UB-311 Alzheimer's Vaccination Trial references APOE

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

SciDEX — scidex.ai — Dashboard | Atlas